Actinogen Enrolls Final Participant In Xanamia Alzheimer`s Trial
18 Dec 2025 //
GLOBENEWSWIRE
Actinogen secures FDA Agreement to Advance Xanamem for Alzheimer
15 Sep 2025 //
GLOBENEWSWIRE
Huadong Medicine Reports Positive Phase I Results For GLP-1 Agonist HDM1002
26 Jun 2024 //
PR NEWSWIRE

Market Place
Sourcing Support